Trial Profile
Clinical Trials Insight: 700053425
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2010
Price :
$35
*
At a glance
- Drugs AGT 190 (Primary)
- Indications Parkinson's disease; Stroke
- Focus Adverse reactions; Pharmacokinetics
- 09 Feb 2010 New trial record